{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:50:26Z","timestamp":1774421426413,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82501067"],"award-info":[{"award-number":["82501067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["8237061080"],"award-info":[{"award-number":["8237061080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Project of Xi\u2019an Science and Technology Bureau","award":["24YXYJ0102"],"award-info":[{"award-number":["24YXYJ0102"]}]},{"name":"Medical Research Project of Xi\u2019an Science and Technology Bureau","award":["24YXYJ0006"],"award-info":[{"award-number":["24YXYJ0006"]}]},{"name":"he Shaanxi Province Natural Science Foundation","award":["No. 2023-JC-YB-754"],"award-info":[{"award-number":["No. 2023-JC-YB-754"]}]},{"name":"First Affiliated Hospital of Xi\u2019an JiaoTong University Foundation","award":["No. 2022MS-04"],"award-info":[{"award-number":["No. 2022MS-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02488-5","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:16:13Z","timestamp":1773213373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2\/STAT3 and PI3K\/Akt Signaling Pathway"],"prefix":"10.1007","volume":"49","author":[{"given":"Zechao","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingfei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiawei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"10086","key":"2488_CR1","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester, G. R., and J. E. Pope. 2017. Novel treatment strategies in rheumatoid arthritis. Lancet 389(10086):2338\u20132348.","journal-title":"Lancet"},{"issue":"11","key":"2488_CR2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/ard-2022-222605","volume":"81","author":"Y Qin","year":"2022","unstructured":"Qin, Y., M. L. Cai, H. Z. Jin, W. Huang, C. Zhu, A. Bozec, J. Huang, and Z. Chen. 2022. Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-\u03b1-mediated ERK1\/2 and JAK-STAT1 pathways. Annals Of The Rheumatic Diseases 81(11):1504\u20131514.","journal-title":"Annals Of The Rheumatic Diseases"},{"issue":"10416","key":"2488_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo, A., J. M. Bathon, and P. Emery. 2023. Rheumatoid arthritis. Lancet 402(10416):2019\u20132033.","journal-title":"Lancet"},{"key":"2488_CR4","doi-asserted-by":"publisher","first-page":"113126","DOI":"10.1016\/j.biopha.2022.113126","volume":"151","author":"R Ben Mrid","year":"2022","unstructured":"Ben Mrid, R., N. Bouchmaa, H. Ainani, R. El Fatimy, G. Malka, and L. Mazini. 2022. Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis. Biomedicine & Pharmacotherapy 151:113126.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"12","key":"2488_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41584-023-01037-w","volume":"19","author":"J Brock","year":"2023","unstructured":"Brock, J., N. Basu, J. C. M. Schlachetzki, G. Schett, I. B. McInnes, and J. Cavanagh. 2023. Immune mechanisms of depression in rheumatoid arthritis. Nature Reviews Rheumatology 19(12):790\u2013804.","journal-title":"Nature Reviews Rheumatology"},{"issue":"6","key":"2488_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese, E. M., and G. S. Firestein. 2023. Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. New England Journal Of Medicine 388(6):529\u2013542.","journal-title":"New England Journal Of Medicine"},{"issue":"7","key":"2488_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41590-023-01527-9","volume":"24","author":"MH Smith","year":"2023","unstructured":"Smith, M. H., V. R. Gao, P. K. Periyakoil, A. Kochen, E. F. DiCarlo, S. M. Goodman, T. M. Norman, L. T. Donlin, C. S. Leslie, and A. Y. Rudensky. 2023. Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis. Nature Immunology 24(7):1200\u20131210.","journal-title":"Nature Immunology"},{"key":"2488_CR8","doi-asserted-by":"publisher","first-page":"112394","DOI":"10.1016\/j.intimp.2024.112394","volume":"137","author":"M Sun","year":"2024","unstructured":"Sun, M., Q. Wang, J. Huang, Q. Sun, Q. Yu, X. Liu, and Z. Liu. 2024. Asiatic acid induces ferroptosis of RA-FLS via the Nrf2\/HMOX1 pathway to relieve inflammation in rheumatoid arthritis. International Immunopharmacology 137:112394.","journal-title":"International Immunopharmacology"},{"issue":"2","key":"2488_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/art.42391","volume":"75","author":"E Morand","year":"2023","unstructured":"Morand, E., M. Pike, J. T. Merrill, R. van Vollenhoven, V. P. Werth, C. Hobar, N. Delev, V. Shah, B. Sharkey, and T. Wegman et al. 2023. Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 75(2):242\u2013252.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"2488_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41584-024-01093-w","volume":"20","author":"E Morand","year":"2024","unstructured":"Morand, E., J. F. Merola, Y. Tanaka, D. Gladman, and R. Fleischmann. 2024. TYK2: an emerging therapeutic target in rheumatic disease. Nature Reviews Rheumatology 20(4):232\u2013240.","journal-title":"Nature Reviews Rheumatology"},{"issue":"17","key":"2488_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s40265-022-01796-y","volume":"82","author":"SM Hoy","year":"2022","unstructured":"Hoy, S. M. 2022. Deucravacitinib: First Approval. Drugs 82(17):1671\u20131679.","journal-title":"Drugs"},{"issue":"11","key":"2488_CR12","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s40264-024-01461-1","volume":"47","author":"L Skaarup","year":"2024","unstructured":"Skaarup, L., E. Ingrid, A. Sepriano, E. Nikiphorou, R. \u00d8stg\u00e5rd, K. Lauper, I. Grosse-Michaelis, M. Kloppenburg, B. Glintborg, and D. F. L. Liew et al. 2024. A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a Safety Checklist. Drug Safety 47(11):1075\u20131093.","journal-title":"Drug Safety"},{"issue":"5","key":"2488_CR13","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","volume":"21","author":"M Akiyama","year":"2022","unstructured":"Akiyama, M., and Y. Kaneko. 2022. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev 21(5):103056.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2488_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen, Z., A. Bozec, A. Ramming, and G. Schett. 2019. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nature Reviews Rheumatology 15(1):9\u201317.","journal-title":"Nature Reviews Rheumatology"},{"key":"2488_CR15","doi-asserted-by":"publisher","unstructured":"Lu, S., C. Cao, W. Zhang, J. Li, J. Yang, Z. Huang, Z. Wu, B. Liu, H. Huang, and H. Wang et al. 2025. Peficitinib suppresses diffuse-type tenosynovial giant cell tumor by targeting TYK2 and JAK\/STAT signaling. Sci China Life Sci 68(3):593-609. https:\/\/doi.org\/10.1007\/s11427-024-2790-7","DOI":"10.1007\/s11427-024-2790-7"},{"key":"2488_CR16","doi-asserted-by":"publisher","first-page":"114791","DOI":"10.1016\/j.jep.2021.114791","volume":"284","author":"Y Shen","year":"2022","unstructured":"Shen, Y., L. Teng, Y. Qu, J. Liu, X. Zhu, S. Chen, L. Yang, Y. Huang, Q. Song, and Q. Fu. 2022. Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-\u03baB and MAPK signaling pathways. Journal Of Ethnopharmacology 284:114791.","journal-title":"Journal Of Ethnopharmacology"},{"key":"2488_CR17","doi-asserted-by":"publisher","unstructured":"Choi, E., C. R. Machado, T. Okano, D. Boyle, W. Wang, and G. S. Firestein. 2024. Joint-specific rheumatoid arthritis fibroblast-like synoviocyte regulation identified by integration of chromatin access and transcriptional activity. JCI Insight 9(12):e179392. https:\/\/doi.org\/10.1172\/jci.insight.179392","DOI":"10.1172\/jci.insight.179392"},{"issue":"1","key":"2488_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13059-021-02460-6","volume":"22","author":"X Ge","year":"2021","unstructured":"Ge, X., M. Frank-Bertoncelj, K. Klein, A. McGovern, T. Kuret, M. Houtman, B. Burja, R. Micheroli, C. Shi, and M. Marks et al. 2021. Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritability. Genome Biology 22(1):247.","journal-title":"Genome Biology"},{"issue":"14","key":"2488_CR19","doi-asserted-by":"publisher","first-page":"13917","DOI":"10.1021\/acsnano.3c03828","volume":"17","author":"S Tao","year":"2023","unstructured":"Tao, S., H. Yu, T. You, X. Kong, X. Wei, Z. Zheng, L. Zheng, Z. Feng, B. Huang, and X. Zhang et al. 2023. A Dual-Targeted Metal-Organic Framework Based Nanoplatform for the Treatment of Rheumatoid Arthritis by Restoring the Macrophage Niche. Acs Nano 17(14):13917\u201313937.","journal-title":"Acs Nano"},{"key":"2488_CR20","doi-asserted-by":"publisher","first-page":"155512","DOI":"10.1016\/j.phymed.2024.155512","volume":"128","author":"XH Wang","year":"2024","unstructured":"Wang, X. H., C. P. Shen, T. T. Wang, Y. Huang, Y. Jin, M. Y. Zhou, M. Y. Zhang, S. L. Gu, M. Q. Wang, and Z. C. Liu et al. 2024. Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via modulation of the AMPK\/mTOR\/ULK-1 signaling pathway. Phytomedicine 128:155512.","journal-title":"Phytomedicine"},{"issue":"1","key":"2488_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12967-023-04730-2","volume":"21","author":"Y Jia","year":"2023","unstructured":"Jia, Y., B. Feng, X. Ji, X. Tian, L. Zhao, J. Zhou, W. Zhang, M. Li, Y. Fei, and X. Wu. 2023. Complement factor H attenuates TNF-\u03b1-induced inflammation by upregulating EIF3C in rheumatoid arthritis. J Transl Med 21(1):846.","journal-title":"J Transl Med"},{"issue":"1","key":"2488_CR22","doi-asserted-by":"publisher","first-page":"e10366","DOI":"10.1002\/btm2.10366","volume":"8","author":"C Ding","year":"2023","unstructured":"Ding, C., L. Ni, Q. Liu, C. Zhou, G. Wang, P. K. Chu, and Z. Wu. 2023. Cold air plasma improving rheumatoid arthritis via mitochondrial apoptosis pathway. Bioeng Transl Med 8(1):e10366.","journal-title":"Bioeng Transl Med"},{"key":"2488_CR23","doi-asserted-by":"publisher","unstructured":"Koper-Lenkiewicz, O. M., K. Sutkowska, N. Wawrusiewicz-Kurylonek, E. Kowalewska, and J. Matowicka-Karna. 2022. Proinflammatory Cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-\u03b1) Single Nucleotide Polymorphisms in Rheumatoid Arthritis-A Literature Review. Int J Mol Sci 23(4):2106. https:\/\/doi.org\/10.3390\/ijms23042106","DOI":"10.3390\/ijms23042106"},{"key":"2488_CR24","doi-asserted-by":"publisher","first-page":"111933","DOI":"10.1016\/j.intimp.2024.111933","volume":"132","author":"Y Lin","year":"2024","unstructured":"Lin, Y., Y. Chen, W. Hu, X. Liu, W. Hao, J. Xing, J. Ding, Y. Xu, F. Yao, and Y. Zhao et al. 2024. TRPM7 facilitates fibroblast-like synoviocyte proliferation, metastasis and inflammation through increasing IL-6 stability via the PKC\u03b1-HuR axis in rheumatoid arthritis. International Immunopharmacology 132:111933.","journal-title":"International Immunopharmacology"},{"issue":"Pt A","key":"2488_CR25","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.intimp.2020.107064","volume":"89","author":"M Masoumi","year":"2020","unstructured":"Masoumi, M., M. Mehrabzadeh, S. Mahmoudzehi, M. J. Mousavi, S. Jamalzehi, A. Sahebkar, and J. Karami. 2020. Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: Latest evidence and therapeutic approaches in rheumatoid arthritis. International Immunopharmacology 89(Pt A):107064.","journal-title":"International Immunopharmacology"},{"key":"2488_CR26","doi-asserted-by":"publisher","unstructured":"Ikari, Y., T. Isozaki, Y. Tsubokura, and T. Kasama. 2019. Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. Cells 8(6):561. https:\/\/doi.org\/10.3390\/cells8060561","DOI":"10.3390\/cells8060561"},{"issue":"1","key":"2488_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s10020-022-00432-5","volume":"28","author":"KS El-Said","year":"2022","unstructured":"El-Said, K. S., A. Atta, M. A. Mobasher, M. O. Germoush, T. M. Mohamed, and M. M. Salem. 2022. Quercetin mitigates rheumatoid arthritis by inhibiting adenosine deaminase in rats. Molecular Medicine 28(1):24.","journal-title":"Molecular Medicine"},{"issue":"1","key":"2488_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue, C., Q. Yao, X. Gu, Q. Shi, X. Yuan, Q. Chu, Z. Bao, J. Lu, and L. Li. 2023. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther 8(1):204.","journal-title":"Signal Transduct Target Ther"},{"key":"2488_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2021.04.027","volume":"512","author":"P Tavakoli Shirazi","year":"2021","unstructured":"Tavakoli Shirazi, P., L. N. Eadie, E. C. Page, S. L. Heatley, J. B. Bruning, and D. L. White. 2021. Constitutive JAK\/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia. Cancer Letters 512:28\u201337.","journal-title":"Cancer Letters"},{"issue":"8","key":"2488_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/annrheumdis-2019-215062","volume":"78","author":"T Motegi","year":"2019","unstructured":"Motegi, T., Y. Kochi, K. Matsuda, M. Kubo, K. Yamamoto, and Y. Momozawa. 2019. Identification of rare coding variants in TYK2 protective for rheumatoid arthritis in the Japanese population and their effects on cytokine signalling. Annals Of The Rheumatic Diseases 78(8):1062\u20131069.","journal-title":"Annals Of The Rheumatic Diseases"},{"key":"2488_CR31","doi-asserted-by":"publisher","unstructured":"Dragotto, M., M. D\u2019Onghia, E. Trovato, L. Tognetti, P. Rubegni, and L. Calabrese. 2024. Therapeutic Potential of Targeting the JAK\/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition. J Clin Med 13(11):3091. https:\/\/doi.org\/10.3390\/jcm13113091","DOI":"10.3390\/jcm13113091"},{"key":"2488_CR32","doi-asserted-by":"publisher","first-page":"1046810","DOI":"10.3389\/fimmu.2022.1046810","volume":"13","author":"RL Li","year":"2022","unstructured":"Li, R. L., H. X. Duan, Q. Liang, Y. L. Huang, L. Y. Wang, Q. Zhang, C. J. Wu, S. Q. Liu, and W. Peng. 2022. Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis. Frontiers In Immunology 13:1046810.","journal-title":"Frontiers In Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02488-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:34:31Z","timestamp":1774416871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02488-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2488"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02488-5","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care and experimental procedures were approved by Animal Care Committee of Hong-Hui Hospital, Xi\u2019an Jiaotong University College of Medicine and conducted strictly followed by \u201cthe institutional guidelines for the care and use of laboratory animals at the Jiaotong University College of Medicine \u201c.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"114"}}